drugset / Trial / NCT07357584
Efficacy and Safety of Doravirine in the Rapid Initiation
Phase 4
Recruiting
100 enrolled
Fundación Huésped
Fundacion IDEAA · collabMSD Pharmaceuticals LLC · collab
NaSingle-groupOpen-labelTreatment
Summary
Protocol title: "Efficacy and safety of doravirine in the rapid initiation of highly active antiretroviral therapy (HAART) in HIV-1positive patients without prior treatment."
Timeline
- Start
- 2026-09-16
- Primary completion
- 2028-04-30
- Completion
- 2028-04-30
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Doravirine | Small molecule | 100 mg | Oral |
| Subject | Lamivudine | Other / unclassified | 300 mg | Oral |
| Subject | Tenofovir disoproxil fumarate | Small molecule | 245 mg | Oral |